A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

Clinical trial NCT04612790 · TERMINATED

Trial details

NCT number: NCT04612790
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Bullous Pemphigoid

Start date: 2021-03-31
Primary completion: 2023-10-26
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.